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Objectives: Our previous longitudinal multicenter-based carriage study showed
that the average carriage rate of Streptococcus pneumoniae was 16.8% in 582
healthy children attending kindergarten or elementary school in Seoul, Korea.
We assessed serotype-specific prevalence and antimicrobial resistance among
colonizing pneumococcal isolates from young children in the era of low use of the
seven-valent pneumococcal conjugate vaccine (PCV7).
Methods: Serotypes were determined by an agglutination test with specific
antisera or by a multiplex polymerase chain reaction (PCR) assay. An antimi-
crobial susceptibility test was performed with broth microdilution in Korean 96-
well panels from Dade-MicroScan (Sacramento, CA, USA).
Results: Pneumococcal colonization patterns were dynamic and longterm
persistent carriage was rare, which indicated a sequential turnover of pneumo-
coccal strains. Of the 369 pneumococci (except for 23 killed isolates), 129
(34.9%) isolates were PCV7 vaccine serotypes (VTs); 213 (57.8%) isolates were
nonvaccine serotypes (NVTs); and the remaining 27 (7.2%) isolates were non-
typable (NT). The highest rates of multidrug resistance (MDR) were observed in
VTs (86.0%; 111/129 isolates) and NVTs (70.0%; 149/213 isolates).
Conclusion: This study overall showed the frequent carriage of VTs and NVTs
with MDR in healthy children attending kindergarten or elementary school. Ef-
forts should be directed toward reducing the extensive prescription of antibiotics
and using new broader vaccines to reduce the expansion of MDR strains of NVTs in
our community.ted under the terms of the Creative Commons Attribution Non-Commercial License (http://
) which permits unrestricted non-commercial use, distribution, and reproduction in any
operly cited.
ase Control and Prevention. Published by Elsevier Korea LLC. All rights reserved.
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Asymptomatic pneumococcal colonization is very
prevalent in the upper respiratory tracts of young chil-
dren, and ranges 20e70% with levels falling with
increasing age [1]. This colonization is a source of
transmission to other individuals and a prerequisite for
the development of respiratory infections [2]. Pneumo-
coccal colonization rarely progresses to local or sys-
temic disease; however, pediatric nasal carriage is a
reservoir of disease-causing pneumococci circulating
within a community [3].
A pneumococcal capsule is a key factor that de-
termines disease outcomes. More than 92 serotypes have
been identified on the basis of antigenic differences in
the capsular polysaccharide [4,5]. Many epidemiolog-
ical studies have shown that serotype distribution differs
with respect to invasive pneumococcal disease (IPD)
and carriage, and certain serotypes have much higher
potential for invasiveness [5e7].
The seven-valent pneumococcal conjugate vaccine
(PCV7), which targets seven serotypes that are highly
relevant to IPD in children, is efficacious in preventing
IPD in vaccinated young children and in unvaccinated
persons [8,9]. After the implementation of the PCV7 in
the National Immunization Program (NIP), the preva-
lence of pneumococcal serotypes has undergone a sig-
nificant shift with a reduction in PCV7 vaccine
serotypes (VTs) and an increase in nonvaccine serotypes
(NVTs) in pneumococcal disease and carriage in many
communities [8e10]. These changes create a need for a
novel expanded-coverage vaccine for pneumococcal
diseases [11]. However, pneumococcal conjugate vac-
cines with limited serotypes do not cover all pneumo-
coccal serotypes that cause disease.
Since November 2003, the PCV7 has been volun-
tarily adopted by the private sector in Korea. This vac-
cine is still not included in the NIP in our community;
therefore, PCV7 coverage may be smaller in our com-
munity than in countries with a routine PCV7 NIP. The
evidence of PCV7 impact on the distribution of pneu-
mococcal serotypes is not fully clear in our community.
Several observational studies indicate that the serotype-
specific distribution of IPD and respiratory disease have
changed in response to even low use of PCV7 in Korea
[12,13].
Our previous longitudinal carriage study described
the nasal carriage and co-colonization patterns of four
potential respiratory pathogens in young Korean chil-
dren through four consecutive examinations over the
course of 1 year; the average carriage rate of Strepto-
coccus pneumoniae was 16.8% in 582 healthy children
aged 3e10 years [14]. Because the true burden of IPD
has not been defined in Korea, the distribution of sero-
types in pneumococcal carriage can provide an addi-
tional useful insight into the impact of partial vaccinepressure on pneumococcal disease. In this study, we
assessed serotype-specific prevalence and antimicrobial
resistance among longitudinally colonizing pneumo-
coccal isolates from young children attending kinder-
garten and/or elementary-school in Seoul, the capital of
Korea, in the era of low use of the PCV7.2. Materials and Methods
2.1. Bacterial isolates
At four sampling times (June 2006, September 2006,
December 2006, and February 2007), a total of 392 S.
pneumoniae strains were isolated from 2328 nasal as-
pirates of 582 healthy child volunteers attending three
kindergartens (165 children with a mean age of
5.6  1.2 years) or attending the first 2 years of one
elementary school (417 children with a mean age of
8.4  0.6 years). This procedure was based on our
previous longitudinal multicenter-based carriage study
[14]. All isolates were examined for a-hemolytic col-
onies with typical pneumococcal morphology and were
identified by conventional procedures [13].
2.2. Serotyping
Pneumococcal serogroups and serotypes were pri-
marily identified by using a chessboard with a com-
mercial Pneumotest-Latex agglutination kit (Statens
Serum Institut, Copenhagen, Denmark) and further
analyzed by the capsular swelling (Quellung reaction)
test with type/group-specific antisera (Staten Serum
Institut, Copenhagen, Denmark). When the serotype of
an isolate could not be determined by the agglutination
test with pooled or specific antisera, the serotype was
determined by a multiplex polymerase chain reaction
(PCR) assay, as described at www.cdc.gov/ncidod/
biotech/strep/pcr.htm. Because of the recently recog-
nized serological cross-reactivity of serotype 6C with
serotype 6A, all apparent serotype 6A strains were
differentiated by a serotype 6C-specific PCR [15].
2.3. Antimicrobial susceptibility test
The minimum inhibitory concentrations of amoxi-
cillin/clavulanate, azithromycin, cefaclor, cefotaxime,
chloramphenicol, clindamycin, erythromycin, levo-
floxacin, penicillin, tetracycline, and trimethoprim/sul-
famethoxazole were determined by broth microdilution
in Korean microbroth 96-well panels manufactured by
Dade-MicroScan (Sacramento, CA, USA); the Clinical
and Laboratory Standards Institute (CLSI) guidelines
were followed [16]. Minimum inhibitory concentration
interpretive criteria followed the most recent CLSI
guidelines by using oral breakpoints for penicillin (i.e.,
susceptible,  0.06 mg/mL; intermediate, 0.12e1 mg/
mL; resistant,  2 mg/mL). Multidrug resistance (MDR)
was defined as nonsusceptibility to three or more anti-
microbial classes such as penicillin (amoxicillin/
318 S. Lee, et alclavulanate); macrolides (erythromycin and/or azi-
thromycin); clindamycin; cephalosporins (cefaclor and/
or cefotaxime); chloramphenicol; trimethoprim/sulfa-
methoxazole; and tetracycline.
2.4. Statistical analysis
The statistical analysis was performed with a two-
sided Fisher’s exact test by using SAS software version
9.2 (SAS Institute, Cary, NC, USA) to compare
kindergarten and elementary school children in carriage
prevalence, serotype distribution, and the resistance rate
between VTs and NVTs and the MDR rate. We
considered a p < 0.05 as statistically significant.3. Results
3.1. Divergent pneumococcal carriage status
Among the 582 healthy child volunteers without
respiratory symptoms, 45.4% (264) children were
colonized at least once with S. pneumoniae during the 1-
year longitudinal carriage study (Table 1). In the four
sampling times, occurring at approximately 3-month
intervals, each child had divergent patterns of pneumo-
coccal carriage. In total, 264 carriers were occasionally
carrying one colonizing S. pneumoniae strain [167
(28.7%) children] or two S. pneumoniae strains [69
(11.9%) children] at the four sampling points. In this
study, persistent carriers who were positive at all four
time points were very rare (0.5%). The frequency of
pneumococcal carriage decreased with age. For the
elementary school children, the proportion was signifi-
cantly higher for the noncarriers (62.8%) than for the
kindergarten children (33.9%; p < 0.0001). ElementaryTable 1. Carriage status of Streptococcus pneumoniae among 5
Carriage Frequency
1st 2nd 3rd 4th No. of children Total (n Z 582) Kinderg
C C C C 3 3 (0.5)
C C C e 6 25 (4.3)
C C e C 7
C e C C 2
e C C C 10
C C e e 13 69 (11.9)
C e C e 12
C e e C 10
e C C e 15
e C e C 7
e e C C 12
C e e e 47 167 (28.7)
e C e e 31
e e C e 55
e e e C 34
e e e e 318 318 (54.6)
Data are presented as n (%). “C” Z Streptococcus pneumoniae isolated; “eschool children relatively rarely exhibit repeated colo-
nization by pneumococcus.3.2. Prevalent serotype distribution
Table 2 shows the prevalent serotypes of the carriage
isolates. These 19 serotypes accounted for 81.3% of 369
isolates (excluding 23 killed isolates). The proportion of
VTs and NVTs was 34.9% and 57.8%, respectively. The
remaining 7.2% were nontypable (NT). Among the VTs,
the most predominant were 6B (9.2%), 19F (7.3%), and
23F (7.3%). Among all 35 NVTs, the most frequent was
35B (6.0%), 6A (5.1%), 15A (4.9%), 37 (4.9%), 19A
(4.6%), and 10A (4.3%). In the two age groups, the
proportion of children who carried VTs and NVTs did
not exhibit a statistically significant difference
(p Z 0.5038). However, certain serotypes showed
different patterns by age group: serotypes 15A and 23A
were relatively abundant among children attending
kindergarten (p Z 0.004 and p Z 0.033, respectively),
and serotypes 18C, 34, and 37 were frequent in the
elementary school children (pZ 0.020, pZ 0.020, and
p Z 0.001, respectively).3.3. Antimicrobial resistance
An in vitro antimicrobial susceptibility test was per-
formed on 364 S. pneumoniae isolates (28 isolates were
excluded because of viability loss during storage).
Figure 1 summarizes the findings. The prevalence of
MDR was 76.9% in the pneumococcal carriage isolates.
The highest resistance was evident for penicillin
(78.6%), erythromycin (75.8%), azithromycin (75.5%),
cefaclor (76.6%), and tetracycline (79.9%), whereas
14.0% and 13.7% of all isolates were nonsusceptible to82 children during a 1-year longitudinal nasal carriage study
No. (%) of Children Colonized
arten (n Z 165) Elementary school (n Z 417) p
3 (1.8) 0 (0.0) 0.0225
17 (10.3) 8 (1.9) <0.0001
38 (23.0) 31 (7.4) <0.0001
51 (30.9) 116 (27.8) 0.4774
56 (33.9) 262 (62.8) <0.0001
“ Z Streptococcus pneumoniae not isolated.
Table 2. Prevalence of PCV7 serotypes and NVTs in 369 Streptococcus pneumoniae isolates (except for 23 killed isolates)
from 582 children attending kindergarten or elementary school during a 1-year longitudinal nasal carriage study
Serotypes
%
Total (n Z 369) Kindergarten (n Z 180) Elementary school (n Z 189)
PCV7
4 1.1 0.6 1.6
6B 9.2 8.3 10.1
9V 3.8 3.3 4.2
14 3.5 5.6 1.6
18C 2.7 0.6 4.8
19F 7.3 6.7 7.9
23F 7.3 7.8 6.9
Vaccine coverage 35.0 32.8 37.0
Non-PCV7
3 3.0 1.1 4.8
6A 5.1 6.7 3.7
7F 3.0 1.7 4.2
10A 4.3 3.3 5.3
11A 2.2 2.2 2.1
15A 4.9 8.9 1.1
19A 4.6 5.0 4.2
23A 2.2 3.9 0.5
34 2.7 0.6 4.8
35A 3.5 4.4 2.6
35B 6.0 7.8 4.2
37 4.9 1.1 8.5
Othersa 11.4 12.1 10.6
Nonvaccine coverage 57.7 58.9 56.6
Nontypable 7.3 8.3 6.4
aOthers include serotypes 1, 7C, 8, 9N, 11C, 12F, 13, 15B, 15C, 15F, 16F, 17F, 22F, 23B, 24F, 25A, 29, 33F, 35F, and 38. NVTsZ nonvaccine serotype;
PCV7 Z seven-valent pneumococcal conjugate vaccine.
MDR NVT pneumococci prevalence in healthy children 319amoxicillin/clavulanate and cefotaxime, respectively.
All isolates were susceptible to levofloxacin.
Resistance to seven tested antimicrobial agents was
higher in the carriage isolates from the kindergarten
children than from the elementary school children, as
follows: penicillin (92.1% vs. 65.8%; p < 0.0001);Figure 1. The proportion of antimicrobial nonsusceptibility of pn
elementary school). AMC Z amoxicillin/clavulanate; AZM Z
CLI Z clindamycin; CTX Z cefotaxime; ERY Z erythromy
SXT Z trimethoprim/sulfamethoxazole; TET Z tetracycline. LVXerythromycin (86.4% vs. 65.8%; p < 0.0001); azi-
thromycin (84.7% vs. 66.8%; p < 0.0001); tetracycline
(89.3% vs. 71.1%; p < 0.0001); cefaclor (88.7% vs.
65.2%; p < 0.0001); clindamycin (62.1% vs. 47.6%;
p Z 0.0062); chloramphenicol (39.0% vs. 23.0%;
p Z 0.0010); and trimethoprim-sulfamethoxazoleeumococcal carriage strains, according to age (kindergarten or
azithromycin; CEC Z cefaclor; CHL Z chloramphenicol;
cin; MDR Z multidrug resistance; PEN Z penicillin G;
Z levofloxacin.
320 S. Lee, et al(58.8% vs. 41.7%; p Z 0.0016). However, the percent
of strains that were nonsusceptible to amoxicillin/clav-
ulanate and cefotaxime did not significantly differ with
age. The rate of MDR was significantly higher among
younger children (89.3% in kindergarten children vs.
65.3% in elementary school children; p < 0.0001).
3.4. High prevalence of MDR among VTs and
NVTs
Figure 2 presents the proportions of MDR in indi-
vidual serotypes covered or not covered by the PCV7.
Most VTs tended to have high rates of MDR (
75.0%)dexcept for VT 18C, which had a low MDR
level (30.0%). The most prevalent NVTs (6A, 15A,
19A, 35A, and 35B) had also the highest rates of MDR
( 75.0%). The number of isolates of a given serotype
was relatively small, although the NVTs 11A, 15B, 16F,
and 23A exhibited highly prevalent MDR ( 75.0%).
The highest rates of MDR were observed in VTs and
NVTs. However, MDR was significantly lower among
the NVTs (70.0%; 149/213 isolates) than among the
VTs (86.0%; 111/129 isolates; p Z 0.0015).4. Discussion
A pneumococcal carriage study could be informative
in regard to the serotype distributions of S. pneumoniae
that is circulating within a country because of different
local factors such as the introduction of PCVs and socio-
economic conditions. To our knowledge, alterations in
serotype-specific carriage in children are more likely to
affect the pneumococcal disease potential in a commu-
nity. The outcomes of routine PCV7 vaccination, a key
selective pressure, have resulted in serotype replacement
because of a reduction in VTs and an increase in certain
NVTs in IPD and carriage in many communities
[1,3,10,11].
Our previous longitudinal multicenter-based carriage
study described average pneumococcal carriage rates of
28.6% and 12.2% in healthy preschool children andFigure 2. The proportion of serotype-specific MDR rates in Strept
of each bar indicates the total number of serotype-specific strains.elementary-school children, respectively, based on
measurements obtained at four time points [14]. At the
time of our study in 2006e2007, the PCV7 had been
available in the private sector since 2003. The uptake of
PCV7 was approximately 20e25% in Korean children
who were younger than 2 years of age in 2004e2006
[12]. However, most children recruited in this study
were born during the period of 1996e2003, which was
prior to the introduction of the PCV7, and parents did
not know the PCV7 vaccination status for their children.
This study did not include the status of PCV7 vaccina-
tion for each child. We nevertheless hypothesized that
many of the recruited children had not been vaccinated
with PCV7. Because of the low coverage rate of the
PCV7, we assessed the serotype prevalence and anti-
microbial resistance in pneumococci carried by healthy
children attending three kindergartens or the first 2 years
of one elementary school in Seoul, Korea.
For the longitudinal carriage study, the serotype-
specific carriage status of S. pneumoniae was very
dynamicdfor any pair of two consecutive S. pneumo-
niae isolates from the same children, only a few were
successively colonized by the same serotype (16.7%; 15
of 90 consecutive pairs; data not shown). Among the
persistent carriers colonized by pneumococci for more
than three periods, the carriage isolates with the same
serotype usually persisted for short periods (less than
two periods), indicating the rapid elimination of the
initial strain and the sequential acquisition of a new
pneumococcal strain with another serotype.
Compared to available serotype-specific carriage data
from healthy children prior to the introduction of the
PCV7 (1997e1998) [17], we observed a high preva-
lence (57.8%) of NVTs in S. pneumoniae isolates in this
study. The proportion of VTs decreased, although the
VTs 6B, 19F, and 23F remained dominant. This finding
supports a few direct effects of the PCV7 on the children
recruited in this study. These data could also be
consistent with the findings of our previous report that
indicated that the PCV7 serotypes 19F, 23F, 9V, 6B, and
14 remain prevalent in IPD, despite a declining trend ofococcus pneumoniae nasal carriage isolates. The number on top
MDR Z multidrug-resistant.
MDR NVT pneumococci prevalence in healthy children 321VTs from 69.2% in the pre-PCV7 era (1996e1999) to
50.0% in the post-PCV7 era (2007e2008) in Korean
children younger than 5 years of age [18].
In this study, the frequent colonizing NVTs were
35B, 6A, 15A, 37, 19A, 10A, 35A, 3, and 7F. This
finding was consistent with the replacement serotypes
that were reported in many recent epidemiological
studies or that were predicted to have improved fitness
for pneumococcal carriage [19e22]. There was an
interesting and notably high prevalence of two sero-
groupsdserotype 35 (35A and 35B; 9.5%) and serotype
15 (15A, 15B, 15C, and 15F; 6.8%)dand two immu-
nologically PCV7-related serotypes 6A (5.1%) and 19A
(4.6%). Many countries describe an increase in serotype
19A and a decrease in serotype 6A with the increased
uptake of the PCV7 [19]. By contrast, our study showed
that serotype 6A remained prevalent among pneumo-
coccal carriage isolates. The cross-protection of the
PCV7 does not fully contribute to a decrease in serotype
6A. A similar phenomenon occurred in our IPD study
during the period from 1996e2008 [18].
The most frequent serotypes generally carried in
children tend to demonstrate resistance because of the
greater likelihood of antibiotic exposure [20]. Prior to
the introduction of the PCV7, the highest rates of
penicillin resistance tended to occur in the common
colonizing VTs 6B, 9V, 14, 19F, and 23F. In an
American study and other studies, the use of PCV7
caused an unexpected increase in antimicrobial resis-
tance among NVTs and particularly in serotypes 6A,
19A, and 35B [20,21]. In this study, even more
remarkable was the high prevalence of MDR in most
NVTs (6A, 11A, 15A, 15B, 16F, 19A, 23A, 35A, and
35B). We believe that the frequent prescribing of anti-
microbial drugs may drive the emergence of MDR
strains of NVTs after PCV7 introduction or even
without vaccination in Korea. Such a high MDR rate for
NVTs is similar to the rates for the pneumococcal iso-
lates reported in a previous IPD study [23].
The recent switch from the PCV7 to the newly
approved vaccines PCV10 and PCV13 is likely to be
substantially offset by an increase in eventual non-
PCV10 or PCV13 serotypes. We anticipate the greatest
impact of the PCV13 will be a reduction in the carriage
and disease attributable to 6A and 19A with MDR.
However, partially covered novel vaccines such as
PCV10 and PCV13 will alter the pneumococcal popu-
lation structure in IPD and carriage in our community
and replace nonvaccine-related serotypes. This phe-
nomenon continues to be a clinical problem in this
region.
The design of pneumococcal vaccines has been based
on the serotype distribution of IPD in a community.
Many public health experts recognize that elevated
NVTs in pneumococcal disease and/or carriage with the
use of the PCV7 is a growing problem. The progression
of pneumococcal disease is complex; however, certainNVTs commonly colonize the nasopharynx, thereby
having a greater potential opportunity to cause IPD. In
Korean children younger than 5 years of age, the overall
incidence of IPD remains very rare. Evaluation of
ongoing changes in the ecology of pneumococcus car-
riage necessitates an estimation of the potential impacts
of pneumococcal vaccines and ultimate full control of
pneumococcal disease in our community. To reduce the
rapid expansion of MDR strains of NVTs, further efforts
should be directed toward using more expanded vac-
cines and reducing the extensive prescription of antibi-
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